Disorders of gastric emptying

Textbook of Gastroenterology, Fifth Edition

Volumn 1, Issue , 2009, Pages 903-935

  Parkman, Henry P ^a   Friedenberg, Frank K ^b   Fisher, Robert S ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Delayed gastric emptying (gastroparesis); Disorders with rapid gastric emptying; Functional dyspepsia; Gastric emptying and disorders; Gastrointestinal diseases; Pathogenesis with emphasis on gastric dysmotility; Symptomatic gastroparesis treatment

Indexed keywords

EID: 84873899134     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303254.ch39     Document Type: Chapter

References (321)

1. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological profiles, treatment and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398.
2. Parkman HP, Schwartz SS. Esophagitis and other gastrointestinal disorders associated with diabetic gastroparesis. Arch Intern Med 1987; 147: 1477.
3. Hoogerwerf WA, Pasricha PJ, Kalloo AN, et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999; 94: 1029.
4. Samsom M, Salet GAM, Roelofs JMM, et al. Compliance of the proximal stomach and dyspeptic symptoms in patients with type 1 diabetes mellitus. Dig Dis Sci 1995; 40: 2037.
5. Lemann M, Dederding JP, Flourie B, et al. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. Dig Dis Sci 1991; 36: 1249.
6. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036.
7. Sarnelli G, Caenepeel P, Geypens B, et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783.
8. Jones KL, Wishart JM, Russo A, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24: 1264.
9. Samsom M, Vermeijden JR, Smout AJ, et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care 2003; 26: 3116.
10. Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nuc Med 1991; 18: 229.
11. Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptoms severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141.
12. Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004; 13: 833.
13. Revicki DA, Rentz AM, Tack J, et al. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clinical Gastroenterol Hepatol 2004; 2: 769.
14. Datz FL, Christian PE, Moore J. Gender-related differences in gastric emptying. J Nucl Med 1987; 28: 1204.
15. Gill RC, Murphy PD, Hooper HR, et al. Effect of the menstrual cycle on gastric emptying. Digestion 1987; 36: 168.
16. Quigley EM, Hasler WL, Parkman HP. AGA technical review on nausea and vomiting. Gastroenterology 2001; 120: 263.
17. Herlinger H. Guide to imaging of the small bowel. Gastroenterol Clin North Am 1995; 24: 309.
18. Hornbuckle K, Barnett JL. The diagnosis and work-up of the patient with gastroparesis. J Clin Gastroenterol 2000; 30: 117.
19. Parkman HP, Harris AD, Krevsky B, et al. Gastroduodenal motility and dysmotility: update on techniques available for evaluation. Am J Gastroenterol 1995; 90: 869.
20. Malagelada JR, Rees WD, Mazzotta LJ, et al. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology 1980; 78: 286.
21. Jian R, Ducrot F, Ruskone A, et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. Dig Dis Sci 1989; 34: 657.
22. Corinaldesi R, Stanghellini V, Raiti C, et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987; 28: 300.
23. Tougas GH, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456.
24. Kim DY, Myung SJ, Camilleri M. Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol 2000; 95: 3365.
25. Guo JP, Maurer AH, Fisher RS, et al. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001; 46: 24.
26. Thomforde GM, Camilleri M, Phillips SF, et al. Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med 1995; 36: 93.
27. Camilleri M, Hasler W, Parkman HP, et al. Measurement of gastroduodenal motility in the GI laboratory. Gastroenterology 1998; 115: 747.
28. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986; 91: 94.
29. Hermansson G, Sivertsson R. Gender-related differences in gastric emptying rate of solid meals. Dig Dis Sci 1996; 41: 1994.
30. Fraser R, Horowitz M, Maddox A, et al. Hyperglcaemia slows gastric emptying in type 1 diabetes mellitus. Diabetologia 1990; 30: 675.
31. Kuo B, McCallum RW, Koch K, et al. SmartPill, a novel ambulatory diagnostic test for measuring gastric emptying in health and disease. Gastroenterology 2006; 130(4 Suppl 1): A434.
32. Parkman HP, Hutson A, Sarosiek I, et al. SmartPill capsule for assessment of gastric emptying -comparison with simultaneous gastric emptying scintigraphy [Abstract]. Am J Gastroenterol 2006; 91: S40.
33. Ghoos YF, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104: 1640.
34. Choi MG, Camilleri M, Burton DD, et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998; 93: 92.
35. Chey WD, Shapiro B, Zawadski A, et al. Gastric emptying characteristics of a novel 13C-octanoate labeled muffin meal. J Clin Gastroenterol 2001; 32: 394.
36. Benini L, Sembenini C, Heading RC, et al. Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy. Am J Gastroenterol 1999; 94: 2861.
37. Chen JZ, McCallum RW. Clinical applications of electrogastrography. Am J Gastroenterol 1993; 88: 1324.
38. Chen JDZ, Lin Z, Pan J, et al. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 1996; 41: 1538.
39. Koch KL, Stern RM, Stewart WR, et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 1989; 84: 1069.
40. Jebbink RJ, Samsom M, Bruijs PP, et al. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type 1 diabetes mellitus. Gastroenterology 1994; 107: 1390.
41. Parkman HP, Miller, Knight LC, et al. Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia. J Clin Gastroenterol 1997; 24: 214.
42. Parkman HP, Hasler WL, Barnett JL, Eaker EY. Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force. Neurogastroenterol Motil 2003; 75: 89.
43. Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral function in patients with suspected gastroparesis. Am J Gastroenterol 1997; 92: 1496.
44. Camilleri M. Study of human gastroduodenojejunal motility: applied physiology in clinical practice. Dig Dis Sci 1993; 38: 785.
45. Frank JW, Sarr MG, Camilleri M. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: an analysis of clinical outcome. Am J Gastroenterol 1994; 89: 339.
46. O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology 1995; 108: 1024.
47. Hyman PE, DiLorenzo C, McAdams L, et al. Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol 1993; 88: 832.
48. Verne GN, Eaker EY, Hardy E, et al. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995; 40: 1892.
49. Schvarcz E, Palmer M, Ingberg C, et al. Increased prevalence of upper gastrointestinal symptoms in long-term type I diabetes mellitus. Diabet Med 1996; 13: 478.
50. Kong M-F, Horowitz M, Jones KL, et al. Natural history of diabetic gastroparesis. Diabetes Care 1998; 22: 503.
51. Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24: 1264.
52. Horowitz M, Harding PE, Maddox A, et al. Gastric and oesophageal emptying in insulin-dependent diabetes mellitus. J Gastroenterol Hepatol 1986; 1: 97.
53. Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 151.
54. Yoshida MM, Schuffler MD, Sumi SM. There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. Gastroenterology 1988; 94: 907.
55. Takahashi T, Nakamura K, Itoh H, et al. Impaired expression of nitric oxide synthase in gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 1997; 113: 1535.
56. Ordog T, Takayama I, Kwok W, et al. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49: 1731.
57. He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121: 427.
58. Schwartz JG, Green GM, Guan D, et al. Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care 1996; 19: 468.
59. Frank JW, Saslow SB, Camilleri M, et al. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 1995; 109: 755.
60. Rayner CK, Samsom M, Jones KL, et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24: 371.
61. Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 675.
62. Lam WF, Masclee AAM, de Boer SY, et al. Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans. Digestion 1993; 54: 48.
63. Mizuno Y, Oomura Y. Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study. Brain Res 1984; 307: 109.
64. Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995; 108: 727.
65. Parkman HP, Gonlachanvit S, Hsu C-W, et al. Effect of altering gastric emptying on postprandial glucose following a physiologic meal in type II diabetic patients. Dig Dis Sci 2003; 48: 488.
66. Melga P, Mansi C, Ciuchi E, et al. Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 1997; 20: 55.
67. Ueno N, Inui A, Asakawa A, et al. Erythromycin improves glycaemic control in patients with type II diabetes mellitus. Diabetologia 2000; 43: 411.
68. Jones KL, Horowitz M, Berry M, et al. Blood glucose concentrations influences postprandial fullness in IDDM. Diabetes Care 1997; 29: 1141.
69. Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am 1992; 72: 445.
70. Mathias JR, Fernandez A, Sninsky CA, et al. Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis: motility of the jejunal limb. Gastroenterology 1985; 88: 101.
71. Geldof H, van der Schee EJ, van Blankenstein M, et al. Effects of highly selective vagotomy on gastric myoelectrical activity. Dig Dis Sci 1990; 35: 969.
72. Tobi M, Holtz T, Carethers J, et al. Delayed gastric emptying after laparoscopic anterior highly selective and posterior truncal vagotomy. Am J Gastroenterol 1995; 90: 810.
73. Vassilakis JS, Xynos E, Dasapidis P, et al. The effect of floppy Nissen fundoplication on esophageal and gastric motility in gastroesophageal reflux. Surg Gynecol Obstet 1993; 177: 608.
74. Bais JE, Samsom M, Boudesteijn EA, et al. Impact of delayed gastric emptying on the outcome of antireflux surgery. Ann Surg 2001; 234: 139.
75. Lundell LR, Myers JC, Jamieson GG. Delayed gastric emptying and its relationship to symptoms of "gas bloat" after antireflux surgery. Eur J Surg 1994; 160: 161.
76. Haque M, Pehlivanov N, Moncure M, et al. Is there a shift in symptomatology in patients after laparoscopic Nissen fundoplication? Am J Gastroenterol 2001; 96: S66.
77. Stanghellini V, Malagelada JR. Gastric manometric abnormalities in patients with dyspeptic symptoms after fundoplication. Gut 1983; 24: 790.
78. Hunter RJ, Metz DC, Morris JB, et al. Gastroparesis: a potential pitfall of laparoscopic Nissen fundoplication. Am J Gastroenterol 1996; 91: 2617.
79. Trus TL, Richardson WS, Branum GD, et al. Complications of laparoscopic paraesophageal hernia repair. J Gastrointest Surg 1997; 1: 221.
80. DeVault KR, Floch NR, Achem SR, Hinder RA. Vagal nerve dysfunction before and after antireflux surgery. Am J Gastroenterol 2001; 96: S10.
81. Mun EC, Blackburn GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001; 120: 669.
82. Horowitz M, Cook DJ, Collins PJ, et al. Measurement of gastric emptying after gastric bypass surgery using radionuclides. Br J Surg 1982; 69: 655.
83. Balsiger BM, Poggio JL, Mai J, et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000; 4: 598.
84. Mistiaen W, Vaneerdeweg W, Blockx P, et al. Gastric emptying rate measurement after vertical banded gastroplasty. Obes Surg 2000; 10: 245.
85. Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis -clinical characteristics and longterm outcomes. Am J Gastroenterol 1997; 92: 1501.
86. Barnert J, Dumitrascu DL, Wienbeck M. Gastroesophageal reflux disease: emptying of the proximal and the distal stomach measured by ultrasonography [Abstract]. Gastroenterology 2001; 120: A460.
87. McCallum RW, Berkowitz DM, Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 1981; 80: 285.
88. Keshavarzian A, Bushnell DL, Sontag S, et al. Gastric emptying in patients with severe reflux esophagitis. Am J Gastroenterol 1991; 86: 738.
89. Stacher G, Lenglinger J, Bergmann H, et al. Gastric emptying: a contributory factor in gastro-oesophageal reflux activity?. Gut 2000; 47: 661.
90. Wright RA, Swan P. Gastric emptying in achalasia. Scand J Gastroenterol 1991; 26: 798.
91. Annese V, Caruso N, Accadia L, et al. Gallbladder function and gastric liquid emptying in achalasia. Dig Dis Sci 1991; 36: 1116.
92. Benini L, Castellani G, Sembenini C, et al. Gastric emptying of solid meals in achalasic patients after successful pneumatic dilatation of the cardia. Dig Dis Sci 1994; 39: 733.
93. Tosetti C, Stanghellini V, Tucci A, et al. Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci 2000; 45: 252.
94. Vanderwinden JM, Mailleux P, Schiffmann SN, et al. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med 1992; 327: 511.
95. Vanderwinden JM, Liu H, De Laet MH, et al. Study of the interstitial cells of Cajal in infantile hypertrophic pyloric stenosis. Gastroenterology 1996; 111: 279.
96. Vanderwinden JM, Liu H, Menu R, et al. The pathology of infantile hypertrophic pyloric stenosis after healing. J Pediatr Surg 1996; 31: 1530.
97. Sun WM, Doran SM, Jones KL, et al. Long-term effects of pyloromyotomy on pyloric motility and gastric emptying in humans. Am J Gastroenterol 2000; 95: 92.
98. Honein MA, Paulozzi LJ, Himelright IM, et al. Infantile hyper-trophic stenosis after pertussis prophylaxis with erythromycin. Lancet 1999; 354: 2101.
99. Graadt van Roggen JF, van Krieken JH. Adult hypertrophic pyloric stenosis: case report and review of the literature. J Clin Pathol 1998; 51: 479.
100. Danikas D, Geis WP, Ginalis EM, et al. Laparoscopic pyloroplasty in idiopathic hypertrophic pyloric stenosis in an adult. J Soc Laparoendosc Surg 2000; 4: 173.
101. Perri F, Pastore M, Zicolella A, et al. Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal. Acta Paediatr 2000; 89: 921.
102. Hamlyn AN, McKenna K, Douglas AP. Gastric emptying in coeliac disease. Br Med J 1977; 1257.
103. Fisher RS, Stalzer F, Rock E, et al. Abnormal gallbladder emptying in patients with gallstones. Dig Dis Sci 1982; 27: 1019.
104. Ibrarullah M, Mittal BR, Agarwal DK, et al. Gastric emptying in patients with gallstone disease with or without dyspepsia: effect of cholecystectomy. Aust N Z J Surg 1994; 64: 247.
105. Chowdhury RS, Forsmark CE, Davis RH, et al. Prevalence of gastroparesis in patients with small duct chronic pancreatitis. Pancreas 2003; 26: 235.
106. Lu CL, Chen CY, Luo JC, et al. Impaired gastric myoelectricity in patients with chronic pancreatitis: role of maldigestion. World J Gastroenterol 2005; 11: 372.
107. Collins CE, Francis JL, Thomas P, et al. Gastric emptying time is faster in cystic fibrosis. J Pediatr Gastroent Nutr 1997; 25: 492.
108. Isobe H, Sakai H, Satoh M, et al. Delayed gastric emptying in patients with liver cirrhosis. Dig Dis Sci 1994; 39: 983.
109. Gunal O, Yegen C, Aktan O, et al. Gastric functions in portal hypertension: role of endothelin. Dig Dis Sci 1996; 41: 585.
110. Usami A, Mizukami Y, Onji M. Abnormal gastric motility in liver cirrhosis: roles of secretin. Dig Dis Sci 1998; 43: 2392.
111. Madsen JL, Brinch K, Hansen EF, et al. Gastrointestinal motor function in patients with portal hypertension. Scand J Gastroenterol 2000; 35: 490.
112. Dumitrascu DL, Barnert J, Wienbeck M. Gastric emptying in liver cirrhosis: the effect of the type of meal. Eur J Gastroenterol Hepatol 1997; 9: 1073.
113. Nishibayashi H, Kanayama S, Shinomura Y, et al. Delayed gastric emptying during interferon-alpha therapy in patients with chronic hepatitis C: relief by cisapride. Scand J Gastroenterol 1997; 32: 547.
114. Bonapace ES, Davidoff S, Krevsky B, et al. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 2000; 95: 2838.
115. Tjeerdsma HC, Smout AJPM, Akkermans LMA. Voluntary suppression of defecation delays gastric emptying. Dig Dis Sci 1993; 38: 832.
116. Wasdholtz BD, Anderson AE. Gastrointestinal symptoms in anorexia nervosa: a prospective study. Gastroenterology 1990; 98: 1415.
117. McCallum RW, Grill BB, Lange R, et al. Definition of a gastric emptying abnormality in patients with anorexia nervosa. Dig Dis Sci 1985; 30: 713.
118. Rigaud D, Bedig G, Merrouche M, et al. Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci 1988; 33: 919.
119. Szmukler GI, Young GP, Lichtensein M, et al. A serial study of gastric emptying in anorexia and bulimia. Aust N Z J Med 1990; 20: 220.
120. Kiss A, Bergmann H, Abatzi Th-A, et al. Oesophageal and gastric motor activity in patients with bulimia nervosa. Gut 1990; 31: 259.
121. Chami TN, Andersen AE, Crowell M, et al. Gastrointestinal symptoms in bulimia nervosa: effects of treatment. Am J Gastroenterol 1995; 90: 88.
122. Thumshirn M, Camilleri M, Hanson RB, et al. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol 1998; 275: G314.
123. Malcolm A, Thumshirn MB, Camilleri M, et al. Rumination syndrome. Mayo Clin Proc 1997; 72: 646.
124. Pasricha PJ, Schuster MM, Saudek CD, et al. Cyclic vomiting: association with multiple homeostatic abnormalities and response to ketorolac. Am J Gastroenterol 1996; 91: 2228.
125. Prakash C, Clouse RE. Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants. Am J Gastroenterol 1999; 94: 2855.
126. Abell TL, Kim CH, Malagelada JR. Idiopathic cyclic nausea and vomiting: a disorder of gastrointestinal motility? Mayo Clin Proc 1988; 63: 1169.
127. Namin F, Patel J, Lin Z, et al. Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. Neurogastroenterol Motil 2007; 19: 196.
128. Boles RG, Williams JC. Mitochondrial disease and cyclic vomiting syndrome. Dig Dis Sci 1999; 44: 103S.
129. Tache Y. Cyclic vomiting syndrome: the corticotrophin-releasingfactor hypothesis. Dig Dis Sci 1999; 44(8 Suppl): 79S.
130. Atkinson K, Romano W, Prokopiw I. An unusual cause of gastroparesis demyelinating disease of the medulla. Dig Dis Sci 1998; 43: 1430.
131. Schoen RE, Brandt LJ. A 19-year old woman with unexplained vomiting. Gastroenterology 1993; 104: 302.
132. Mann SC, Danesh BJ, Kamm MA. Intractable vomiting due to a brain-stem lesion in the absence of neurological signs or raised intracranial pressure. Gut 1998; 42: 875.
133. Djaldetti R, Baron J, Ziv I, et al. Gastric emptying in Parkinson's disease. Neurology 1996; 46: 1051.
134. Wakabayashi K, Takahashi H, Takeda S, et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 1988; 76: 217.
135. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997; 92: 976.
136. Weston S, Thumshirn M, Wiste J, et al. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998; 93: 1085.
137. Marie I, Levesque H, Ducrotte P, et al. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol 2001; 96: 77.
138. Wegener M, Adamek RJ, Wedmann B, et al. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994; 39: 2209.
139. Horowitz M, McNeil JD, Maddern GJ, et al. Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis. Gastroenterology 1986; 90: 434.
140. Posthuma EF, Warmerdam P, Chandie Shaw MP, et al. Gastric outlet obstruction as a presenting manifestation of systemic lupus erythematosus. Gut 1994; 35: 841.
141. Lee JG, Wilson JA, Gottfried MR. Gastrointestinal manifestations of amyloidosis. South Med J 1994; 87: 243.
142. Menke DM, Kyle RA, Fleming CR, et al. Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc 1993; 68: 763.
143. Kahraman H, Kaya N, Demircali A, et al. Gastric emptying time in patients with primary hypothyroidism. Eur J Gastroenterol Hepatol 1997; 9: 901.
144. Groskreutz JL, Kim CH, McConahey WM. Acute gastroparesis associated with thyrotoxicosis. Am J Gastroenterol 1990; 85: 1206.
145. Barczynski M, Thor P. Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying. Clin Auton Res 2001; 11: 243.
146. Mok LL, Ajiwe E, Martin TJ, et al. Parathyroid hormone-related protein relaxes rat gastric smooth muscle and shows cross-desensitization with parathyroid hormone. J Bone Miner Res 1989; 4: 433.
147. McNamee PT, Moore GW, McGeown MG, et al. Gastric emptying in chronic renal failure. BMJ 1985; 291: 310.
148. De Schoenmakere G, Vanholder R, Rottey S, et al. Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1850.
149. Dumitrascu DL, Barnert J, Kirschner T, et al. Antral emptying of semisolid meal measured by real-time ultrasonography in chronic renal failure. Dig Dis Sci 1995; 40: 636.
150. van Vlem B, Schoonjans R, Vanholder R, et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 962.
151. Brown-Cartwright D, Smith HJ, Feldman M. Gastric emptying of an indigestible solid in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. Gastroenterology 1988; 95: 49.
152. Kebede D, Barthel JS, Singh A. Transient gastroparesis associated with cutaneous herpes zoster. Dig Dis Sci 1987; 32: 318.
153. Meeroff JC, Schreiber DS, Trier JS, et al. Abnormal gastric motor function in viral gastroenteritis. Ann Intern Med 1980; 92: 370.
154. Nowak TV, Goddard M, Batteiger B, et al. Evolution of acute cytomegalovirus gastritis to chronic gastrointestinal dysmotility in a nonimmunocompromised adult. Gastroenterology 1999; 116: 953.
155. Vassallo M, Camilleri M, Caron BL, et al. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology 1991; 100: 252.
156. Van Thiel DH, Gavaler JS, Schade RR, et al. Cytomegalovirus infection and gastric emptying. Transplantation 1992; 54: 70.
157. Corley DA, Cello JP, Koch J. Evaluation of upper gastrointestinal tract symptoms in patients infected with HIV. Am J Gastroenterol 1999; 94: 2890.
158. Neild PJ, Nijran KS, Yazaki E, et al. Delayed gastric emptying in human immunodeficiency virus infection. Dig Dis Sci 2000; 45: 1491.
159. Konturek JW, Fischer H, Van Der Voort IR, et al. Disturbed motor activity in patients with human immunodeficiency virus infection. Scand J Gastroenterol 1997; 32: 221.
160. Mearin F, de Ribot X, Balboa A, et al. Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 1995; 37: 47.
161. Tucci A, Corinaldesi R, Stanghillini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992; 103: 768.
162. Testoni PA, Bagnolo F, Masci E, et al. Different interdigestive antroduodenal motility patterns in chronic antral gastritis with and without Helicobacter pylori infection. Dig Dis Sci 1993; 38: 2255.
163. Lin Z, Chen JD, Parolisi S, et al. Prevalence of gastric myoelectrical abnormalities in patients with nonulcer dyspepsia and H. pylori infection: resolution after H. pylori eradication. Dig Dis Sci 2001; 46: 739.
164. Casey KM, Quigley TM, Kozarek RA, et al. Lethal nature of ischemic gastropathy. Am J Surg 1993; 165: 646.
165. Liberski SM, Koch KL, Atnip RG, et al. Ischemic gastroparesis: resolution after revascularization. Gastroenterology 1990; 99: 252.
166. Berkowitz N, Schulman LL, McGregor C, et al. Gastroparesis after lung transplant: potential role in postoperative respiratory complications. Chest 1995; 108: 1602.
167. Au J, Hawkins T, Venables C, et al. Upper gastrointestinal dysmotility in heart-lung transplant recipients. J Thorac Surg 1993; 55: 94.
168. Sodhi SS, Guo J-P, Maurer AH, et al. Gastroparesis after combined heart and lung transplantation. J Clin Gastroenterol 2002; 34: 34.
169. Shivshanker K, Bennett RW, Haynie TP. Tumor-associated gastroparesis: correction with metoclopramide. Am J Surg 1983; 145: 221.
170. Osias GL, Tepper RE, Zanzi I, et al. Pseudogastroparesis as a presentation of adenocarcinoma of the proximal jejunum. Am J Gastroenterol 1998; 93: 994.
171. Sikora SS, Mital BR, Prasad KR, et al. Functional gastric impairment in carcinoma of the pancreas. Br J Surg 1995; 82: 1112.
172. Lee HR, Lennon VA, Camilleri M, et al. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001; 96: 373.
173. Schuffler MD, Baird HW, Fleming CR, et al. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. Ann Intern Med 1983; 98: 129.
174. Layer P, Demol P, Hotz J, et al. Gastroparesis after radiation: successful treatment with carbachol. Dig Dis Sci 1986; 31: 1377.
175. Brand RE, DiBaise JK, Quigley EM, et al. Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet 1998; 352: 1985.
176. Eagle DA, Gian V, Lauwers GY, et al. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant 2001; 28: 59.
177. Iftikhar S, Loftus EV. Gastroparesis after celiac plexus block. Am J Gastroenterol 1998; 93: 2223.
178. Parkman HP, Miller MA, Trate DM, et al. Effect of gastric acid suppressants on human gastric motility. Gut 1998; 42: 243.
179. Houghton LA, Read RW. A comparative study of the effect of cimetidine and ranitidine on the rate of gastric emptying of liquid and solid test meals in man. Aliment Pharmacol Ther 1987; 1: 401.
180. Masclee AA, Gielkens HA, Lam WF, et al. Effects of parenteral nutrients on gastrointestinal motility and secretion. Scand J Gastroenterol 1996; 218(Suppl): 50.
181. Casaubon PR, Dahlstrom KA, Vargas J, et al. Intravenous fat emulsion (Intralipid) delays gastric emptying, but does not cause gastroesophageal reflux in healthy volunteers. JPEN J Parenter Enteral Nutr 1989; 13: 246.
182. AMS Gastroparesis Task Force: Abell TL, Bernstein RK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary review. Neurogastroenterol Motil 2006; 18: 263.
183. Camilleri M. Diabetic gastroparesis. N Eng J Med 2007; 356: 820.
184. Parrish CR, Yoshida C. Nutrition intervention for the patient with gastroparesis: an update. Pract Gastroenterol 2005; 29: 29.
185. Moore JG, Christian PE, Coleman RE. Gastric emptying of varying meal weight and composition in man. Dig Dis Sci 1981; 26: 16.
186. Petiakis IE, Vrachassotakis N, Sciacca V, et al. Hyperglycemia attenuates erythromycin-induced acceleration of solid phase gastric emptying in idiopathic and diabetic gastroparesis. Scand J Gastroenterol 1999; 34: 396.
187. Rabine JC, Barnett JL. Management of the patient with gastroparesis. J Clin Gastroenterol 2001; 32: 11.
188. Muth ER, Jokerst M, Stern RM, et al. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness. Aviat Space Environ Med 1995; 66: 1041.
189. Neilsen OH, Hvid-Jacobsen K, Lund P, Langoholz E. Gastric emptying and subjective symptoms of nausea: lack of effects of a 5hydroxytryptamine-3 antagonist ondansetron on gastric emptyng in patients with gastric stasis syndrome. Digestion 1990; 46: 89.
190. Dando TM, Perry CM. Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs 2004; 64: 777.
191. Longstreth GF, Malagelada JR, Kelly KA. Metoclopramide stimulation of gastric motility and emptying in diabetic gastroparesis. Ann Intern Med 1977; 86: 195.
192. Snape WJ, Battle WM, Schwartz SS, et al. Metoclopramide to treat gastroparesis due to diabetes mellitus. Ann Intern Med 1982; 96: 444.
193. Perkel MS, Moore C, Hersh T, et al. Metoclopramide therapy in patients with delayed gastric emptying. Dig Dis Sci 1979; 24: 662.
194. Schade RR, Dugas MC, Lhotsky DM, et al. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 1985; 30: 10.
195. Trapnell BC, Mavko LE, Birskovich LM, et al. Metoclopramide suppositories in the treatment of diabetic gastroparesis. Arch Intern Med 1986; 146: 2278.
196. Ganzini L, Casey DE, Hoffman WF, et al. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993; 153: 1469.
197. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 105: 1886.
198. Parkman HP, Pagano AP, Vozzelli M, et al. The gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in the rabbit stomach. Am J Physiol 1995; 269: G418.
199. Ramirez B, Eaker EY, Drane WE, et al. Erythromycin enhances gastric emptying in patients with gastroparesis after vagotomy and antrectomy. Dig Dis Sci 1994; 39: 2295.
200. Camilleri M. The current role of erythromycin in the clinical management of gastric emptying disorders. Am J Gastroenterol 1993; 88: 169.
201. Janssens J, Peeters TL, Vantrappen G, et al. Erythromycin improves delayed gastric emptying in diabetic gastroparesis. N Engl J Med 1990; 322: 1028.
202. Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomized, double blind, placebo controlled trial. Gut 2001; 49: 395.
203. Ehrenpreis ED, Zaitman D, Nellans H. Which form of erythromycin should be used to treat gastroparesis? A pharmacologic analysis. Aliment Pharmacol Ther 1998; 12: 373.
204. DiBaise JK, Quigley EM. Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis. J Clin Gastroenterol 1999; 28: 131.
205. Patterson D, Abell T, Rothstein R, et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999; 94: 1230.
206. Horowitz M, Harding PE, Chatterton BE, et al. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985; 30: 1.
207. Davis RH, Clench MH, Mathias JR. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms. Dig Dis Sci 1988; 33: 1505.
208. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325: 1461.
209. Edmunds MC, Chen JD, Soykan I, et al. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis. Aliment Pharmacol Ther 1998; 12: 167.
210. Degen L, Matzinger D, Merz M, et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001; 15: 1745.
211. Rosa-e-Silva L, Troncon LES, Oliveira RB, et al. Treatment of diabetic gastroparesis with oral clonidine. Aliment Pharmacol Ther 1995; 9: 179.
212. Thumshirn M, Camilleri M, Cho M-G, et al. Modulation of gastric sensory and motor functions by nitrergic and alpha 2-adrenergic agents in humans. Gastroenterology 1999; 116: 573.
213. Gullikson GW, Virina MA, Loeffler R, et al. Alpha-2-adrenergic model of gastroparesis. Am J Physiol 1991; 261: G426.
214. Kishibayashi N, Karasawa A. Effects of KW-5092 on antroduodenal coordination and gastric emptying in guinea pigs. J Pharm Pharmacol 1998; 50: 1045.
215. Prakash C, Lustman PJ, Freedland KE, et al. Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients. Dig Dis Sci 1998; 43: 1951.
216. Sawhney MS, Prakash C, Lustman PJ, Clouse RE. Tricyclic antidepressants for chronic vomiting in diabetic patients. Dig Dis Sci 2007; 52: 418.
217. Abouezzi ZE, Melvin WS, Ellison EC, et al. Functional and symptomatic improvement in patients with diabetic gastroparesis following pyloroplasty [Abstract]. Gastroenterology 1998; 114: A1374.
218. Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332: 774.
219. Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002; 97: 1653.
220. Lacy BE, Crowell MD, Schettler-Duncan VA, et al. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004; 27: 2341.
221. Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002; 55: 920.
222. Bromer MQ, Friedenberg F, Miller LS, et al. Endoscopic pyloric injection of botulinum toxin A for treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 833.
223. Arts J, Caenepeel P, Degreef T, et al. Randomized double-blind cross-over study evaluating the effect of intrapyloric injection of botulinum toxin on gastric emptying and symptoms in patients with gastroparesis [Abstract]. Gastroenterology 2005; 128: A81.
224. Friedenberg FK, Palit A, Parkman HP, Nelson D. Randomized, placebo-controlled trial of botulinum toxin A for the treatment of delayed gastric emptying [Abstract]. Gastroenterology 2007; 132: M1150.
225. Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, et al. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol 2006; 194: 95.
226. Boone SA, Shields KM. Treating pregnancy-related nausea and vomiting with ginger. Ann Pharmacother 2005; 39: 1710.
227. Lien HC, Sun WM, Chen YH, et al. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol 2003; 284: G481.
228. Gonlachanvit S, Chen YH, Hasler WL, et al. Ginger reduces hyperglycemia-evoked gastric dysrhythmias in healthy humans: possible role of endogenous prostaglandins. J Pharmacol Exp Ther 2003; 307: 1098.
229. Dundee JW, Ghaly RG, Bill KM, et al. Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting. Br J Anaesth 1989; 63: 612.
230. Lin X, Liang J, Ren J, et al. Electrical stimulation of acupuncture points enhances gastric myoelectrical activity in humans. Am J Gastroenterol 1997; 92: 1527.
231. De Aloysio D, Penacchioni P. Morning sickness control in early pregnancy by Neiguan point acupressure. Obstet Gynecol 1992; 80: 852.
232. Kim CH, Nelson DK. Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis. Gastrointest Endosc 1998; 47: 67.
233. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis. Am J Gastroenterol 1996; 91: 2174.
234. Jacober SJ, Narayan A, Stroedel WE, et al. Jejunostomy feeding in the management of gastroparesis diabeticorum. Diabetes Care 1986; 9: 217.
235. Hotokezaka M, Adams RB, Miller AD, et al. Laparoscopic percutaneous jejunostomy for long term enteral access. Surg Endosc 1996; 10: 1008.
236. McCallum RW, Chen JD, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998; 114: 456.
237. Abell TL, Van Cutsem E, Abrahamsson H, et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion 2002; 66: 204.
238. Abell T, McCallum R, Hocking M, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125: 421.
239. Mintchev MP, Sanmiguel CP, Amaris M, et al. Microprocessor-controlled movement of solid gastric content using sequential neural electrical stimulation. Gastroenterology 2000; 118: 258.
240. Forster J, Sarosiek I, Delcore R, et al. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001; 182: 676.
241. Murat A, Pouliquen B, Cantarovich D, et al. Gastric emptying improvement after simultaneous segmental pancreas and kidney transplantation. Transplant Proc 1992; 24: 855.
242. Karlstrom L, Kelly KA. Roux-en-Y gastrectomy for chronic gastric atony. Am J Surg 1989; 157: 44.
243. McCallum RW, Polepalle SC, Schirmer B. Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease. Dig Dis Sci 1991; 36: 1556.
244. Forstner-Barthell AW, Murr MM, Nitecki S, et al. Near-total completion gastrectomy for severe postvagotomy gastric stasis. J Gastrointest Surg 1999; 3: 15.
245. Eckhauser RE, Conrad M, Knol JA, et al. Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. Am Surg 1998; 64: 711.
246. Ejskjaer NT, Bradley JL, Buxton-Thomas MS, et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999; 16: 488.
247. Kennedy WR, Navarro X, Goetz RC, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322: 1031.
248. Hathaway DK, Abell T, Cardoso S, et al. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation 1994; 57: 816.
249. Lamers CB, Bijlstra AM, Harris AG. Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. Dig Dis Sci 1993; 38: 359.
250. Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am 1992; 72: 445.
251. Hasler WL, Soudah HC, Owyang C. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J Pharmacol Exp Ther 1996; 277: 1359.
252. Lin HC, Van Citters GW, Zhao XT, Waxman A. Fat intolerance depends on rapid gastric emptying. Dig Dis Sci 1999; 44: 330.
253. Delgado-Aros S, Camilleri M, Cremonini F, et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127: 1685.
254. Schwartz JG, Green GM, Guan D, et al. Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care 1996; 19: 468.
255. Fajardo NR, Locke GR, Talley NJ. Cyclic vomiting syndrome is associated with rapid early gastric emptying (Abstract). Am J Gastroenterol 2005; 100: 143.
256. Lawal A, Barboi A, Krasnow A, et al. Rapid gastric emtpying is more common than gastroparesis in patients with autonomic dysfunction. Am J Gastroenterol 2007; 102: 618.
257. Ralphs DN, Thomson JP, Haynes S, et al. The relationship between the rate of gastric emptying and the dumping syndrome. Br J Surg 1978; 65: 637.
258. Penning C, Vecht J, Masclee AA. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome. Aliment Pharmacol Ther 2005; 22: 963.
259. Didden P, Penning C, Masclee AA. Octreotide therapy in dumping syndrome: analysis of long-term results. Aliment Pharmacol Ther 2006; 24: 1367.
260. Lin HC, Van Citters GW, Heimer F, Bonorris G. Slowing of gastrointestinal transit by oleic acid. Dig Dis Sci 2001; 46: 223.
261. Vogel SB, Hocking MP, Woodward ER. Clinical and radionuclide evaluation of Roux-en-Y diversion for postgastrectomy dumping. Am J Surg 1988; 155: 57.
262. Phillips WT, Schwartz JG. Decelerating gastric emptying: therapeutic possibilities in type 2 diabetes. Diabet Med 1996; 13: S44.
263. Ray TK, Mansell KM, Knight LC, et al. Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulindependent diabetic patients. Am J Clin Nutr 1983; 37: 376.
264. Chandalia M, Garg A, Lutjohann D, et al. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342: 1392.
265. Long WB, Weiss JB. Rapid gastric emptying of fatty meals in pancreatic insufficiency. Gastroenterology 1974; 67: 920.
266. Regan PT, Malagelada JR, Dimagno EP, et al. Postprandial gastric function in pancreatic insufficiency. Gut 1979; 20: 249.
267. Lam SK, Isenberg JI, Grossman MI, et al. Rapid gastric emptying in duodenal ulcer patients. Dig Dis Sci 1982; 27: 598.
268. Dubois A, Van Eerdewegh P, Gardner JD. Gastric emptying and secretion in Zollinger-Ellison syndrome. J Clin Invest 1977; 59: 255.
269. Tobin MV, Fisken RA, Diggory RT, et al. Orocaecal transit time in health and in thyroid disease. Gut 1989; 30: 26.
270. Jonderko K, Jonderko G, Marcisz C, et al. Gastric emptying in hyperthyroidism. Am J Gastroenterol 1997; 92: 835.
271. Tosetti C, Corinaldesi R, Stanghellini V, et al. Gastric emptying of solids in morbid obestiy. Int J Obes Relat Metab Disord 1996; 20: 200.
272. Wisen O, Hellstrom PM. Gastrointestinal motility in obesity. J Intern Med 1995; 237: 411.
273. Talley NJ, Silverstein MD, Agreus L, et al. AGA technical review: evaluation of dyspepsia. Gastroenterology 1998; 114: 582.
274. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466.
275. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic esophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023.
276. Fisher RS, Parkman HP. Management of nonulcer dyspepsia. N Engl J Med 1998; 339: 1376.
277. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239.
278. Kim DY, Delgado-Aros S, Camilleri M, et al. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001; 96: 3099.
279. Talley NJ, Shuter B, McCrudden G, et al. Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. J Clin Gastroenterol 1989; 11: 625.
280. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001; 96: 1422.
281. Talley NJ, Locke GR 3rd, Tack J. Does delayed gastric emptying really cause symptoms in functional dyspepsia? We still doubt it! Gut 2006; 55: 1674.
282. Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985; 88: 1223.
283. Stanghellini V, Ghidini C, Ricci Maccarini M, et al. Fasting and postprandial gastrointestinal motility in ulcer and nonulcer dyspepsia. Gut 1992; 33: 184.
284. Bjornsson ES, Abrahamsson H. Contractile patterns in patients with severe chronic dyspepsia. Am J Gastroenterol 1999; 94: 54.
285. Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346.
286. Boeckxstaens GE, Hirsch DP, Kuiken SD, et al. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002; 97: 40.
287. Troncon LE, Bennett RJ, Ahluwalia NK, et al. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994; 35: 327.
288. Gonlachanvit S, Maurer AH, Fisher RS, Parkman HP. Regional gastric emptying abnormalities in functional dyspepsia and gastroesophageal reflux disease. Neurogastroenterol Motil 2006; 18: 894.
289. Scott AM, Kellow JE, Shuter B, et al. Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia. Dig Dis Sci 1993; 38: 2247.
290. Gilja OH, Hausken T, Wilhelmsen I, et al. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996; 41: 689.
291. Koch KL, Hong SP, Xu L. Reproducibility of gastric myoelectrical activity and the water load test in patients with dysmotility-like dyspepsia symptoms and in control subjects. J Clin Gastroenterol 2000; 31: 125.
292. Gonenne J, Castillo EJ, Camilleri M, et al. Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil 2005; 17: 44.
293. Delgado-Aros S, Camilleri M, Cremonini F, et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127: 1685.
294. Tack J, Caenepeel P, Piessevaux H, et al. Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 2003; 52: 1271.
295. Lin X, Levanon D, Chen JD. Impaired postprandial gastric slow waves in patients with functional dyspepsia. Dig Dis Sci 1998; 43: 1678.
296. Lin Z, Eaker EY, Sarosiek I, et al. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gastroenterol 1999; 94: 2384.
297. Lin X, Chen JZ. Abnormal gastric slow waves in patients with functional dyspepsia assessed with multichannel electrogastrography. Am J Physiol 2001; 280: G1370.
298. Tack J, Caenepeel P, Fischler B, et al. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Gastroenterology 2001; 121: 526.
299. Samsom M, Vergagen MA, vanBerge Henegouwen GP, et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515.
300. Ladabaum U, Minoshima S, Hasler WL, et al. Gastric distension correlates with activation of multiple cortical and subcortical regions. Gastroenterology 2001; 120: 369.
301. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 660.
302. Mearin F, Balboa A, Zarate N, et al. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 1999; 94: 116.
303. Camilleri M. Pharmacogenomics and functional gastrointestinal disorders. Pharmacogenomics 2005; 6: 491.
304. Dobrilla G, Comberlato M, Steele A, et al. Drug treatment of functional dyspepsia: a meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 169.
305. Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia. Scand J Gastroenterol 1994; 29: 618.
306. Finney JS, Kinnersley N, Hughes M, et al. Meta-analysis of anti-secretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 312.
307. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, et al. Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis. Am J Gastroenterol 2001; 96: 689.
308. Moayyedi P, Soo S, Deeks J, et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; 4: CD001960.
309. Arts J, Caenepeel P, Verbeke K, Tack J. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005; 54: 455-60.
310. Talley NJ, Verlinden M, Snape W, et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000; 14: 1653.
311. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994; 39: 2352.
312. Jackson JL, O'Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000; 108: 65.
313. Loldrup D, Langemark M, Hansen HJ, et al. Clomipramine and mianserin in chronic idiopathic pain syndrome: a placebo controlled study. Psychopharmacology 1989; 99: 1.
314. Mertz H, Rass R, Kodner A, et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 160.
315. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125: 19.
316. Tack J, Bisschops R, DeMarch B. Causes and treatment of functional dyspepsia. Curr Gastroenterol Rep 2001; 3: 503.
317. Kuo B, Camilleri M, Burton D, et al. Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther 2002; 16: 225.
318. Talley NJ, Van Zanten SV, Saez LR, et al. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 525.
319. Tack J, Coulie B, Andrioli A, et al. Influence of sumatriptan on gastric fundus tone and of the perception of gastric distension in man. Gut 2000; 46: 468.
320. Sarnelli G, Sifrim D, Janssens J, Tack J. Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 2004; 287: G988.
321. Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000; 106: 373.